Root Financial Partners
AUPH icon

Root Financial Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

Root Financial Partners’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.1K Buy
+872
New +$13.9K ﹤0.01% 1740
2026
Q2 		– Sell
-811
Closed -$12K – 634
2026
Q1 		$12K Buy
+811
New +$11.9K ﹤0.01% 1585

Other funds holding AUPH

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Cookson Peirce & Co
Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Moran Wealth Management
Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Patten & Patten
Patten & Patten Chattanooga, Tennessee $1.91B AUM 21.06% 1-Year Est. Return
Capital Investment Advisors
Capital Investment Advisors Atlanta, Georgia $7.74B AUM 15.52% 1-Year Est. Return

Root Financial Partners's AUPH Position: Q3 2026 in Review

Root Financial Partners opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 872 shares worth $14.1K. The stake represents ﹤0.01% of the portfolio and ranks #1740 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in AUPH as recently as Q1 2026.

Root Financial Partners first reported a position in AUPH in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Root Financial Partners held 872 shares of Aurinia Pharmaceuticals worth $14.1K as of Q3 2026.
  • Aurinia Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1740 holding.
  • Root Financial Partners first reported a position in Aurinia Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.